Moderna Statistics
Moderna (1MRNA) Stock Statistics & Valuation Metrics
Total Valuation
Moderna has a market cap or net worth of EUR 91.46B. The enterprise value is EUR 81.86B.
- Market Cap
- EUR 91.46B
- Enterprise Value
- EUR 81.86B
Share Statistics
Moderna has 404,620,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 404,620,970
- Owned by Insiders
- 7.68%
- Owned by Institutions
- 61.27%
Financial Efficiency
Moderna’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -29.70%.
- Return on Equity (ROE)
- -0.33
- Return on Assets (ROA)
- -0.23
- Return on Invested Capital (ROIC)
- -29.70%
- Return on Capital Employed (ROCE)
- -0.30
- Revenue Per Employee
- 413.62K
- Profits Per Employee
- -600.43K
- Employee Count
- 4,700
- Asset Turnover
- 0.16
- Inventory Turnover
- 5.67
Valuation Ratios
The current PE Ratio of Moderna is -35.18. Moderna’s PEG ratio is -3.56.
- PE Ratio
- -35.18
- PS Ratio
- 39.85
- PB Ratio
- 14.59
- Price to FCF
- -51.63
- Price to Operating Cash Flow
- -56.53
- PEG Ratio
- -3.56
Income Statement
In the last 12 months, Moderna had revenue of 1.94B and earned -2.82B in profits. Earnings per share was -7.26.
- Revenue
- 1.94B
- Gross Profit
- 1.08B
- Operating Income
- -3.07B
- Pretax Income
- -2.77B
- Net Income
- -2.82B
- EBITDA
- -2.55B
- Earnings Per Share (EPS)
- -7.26
Cash Flow
In the last 12 months, operating cash flow was -1.76B and capital expenditures -185.00M, giving a free cash flow of -1.95B billion.
- Operating Cash Flow
- -1.76B
- Free Cash Flow
- -1.95B
- Free Cash Flow per Share
- -4.86
Dividends & Yields
Moderna pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.94%
- Earnings Yield
- -2.80%
Stock Price Statistics
- Beta
- 0.34
- 52-Week Price Change
- 913.69%
- 50-Day Moving Average
- 168.83
- 200-Day Moving Average
- 80.21
- Relative Strength Index (RSI)
- 58.98
- Average Volume (3m)
- 36.05K
Important Dates
Moderna upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Feb 25, 2027
- Ex-Dividend Date
- ―
Financial Position
Moderna as a current ratio of 3.29, with Debt / Equity ratio of 22.15%
- Current Ratio
- 3.29
- Quick Ratio
- 3.22
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- 0.27
- Interest Coverage Ratio
- -307.40
Taxes
In the past 12 months, Moderna has paid 54.00M in taxes.
- Income Tax
- 54.00M
- Effective Tax Rate
- -0.02
Enterprise Valuation
Moderna EV to EBITDA ratio is -42.20, with an EV/FCF ratio of -53.16.
- EV to Sales
- 41.03
- EV to EBITDA
- -42.20
- EV to Free Cash Flow
- -53.16
- EV to Operating Cash Flow
- -58.74
Balance Sheet
Moderna has EUR 5.17B in cash and marketable securities with EUR 4.18B in debt, giving a net cash position of EUR 992.00M billion.
- Cash & Marketable Securities
- EUR 5.17B
- Total Debt
- EUR 4.18B
- Net Cash
- EUR 992.00M
- Net Cash Per Share
- EUR 2.45
- Tangible Book Value Per Share
- EUR 17.05
Margins
Gross margin is 28.00%, with operating margin of -116.04%, and net profit margin of -110.46%.
- Gross Margin
- 28.00%
- Operating Margin
- -116.04%
- Pretax Margin
- -108.08%
- Net Profit Margin
- -110.46%
- EBITDA Margin
- -97.23%
- EBIT Margin
- -107.41%
Analyst Forecast
The average price target for Moderna is EUR 130.36, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- EUR 130.36
- Price Target Upside
- 41.32% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 20
- Revenue Growth Forecast
- 8.89%
- EPS Growth Forecast
- 18.53%
Scores
- Smart Score
- 7
- AI Score
- ―
